During the past decade, Rocky Mountain Gynecologic Oncology PC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 9 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Gynecologic Oncology PC" #1 collaborator was "NRG Oncology" with 8 trials as a collaborator and "National Cancer Institute (NCI)" with 3 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Rocky Mountain Gynecologic Oncology PC" are "Fallopian Tube Endometrioid Adenocarcinoma" (5 trials), "Fallopian Tube Mucinous Adenocarcinoma" (5 trials), "Fallopian Tube Transitional Cell Carcinoma" (5 trials), "Ovarian Endometrioid Adenocarcinoma" (5 trials) and "Ovarian Serous Adenocarcinoma" (5 trials). Many other conditions were trialed in "Rocky Mountain Gynecologic Oncology PC" in a lesser frequency.

Most popular intervention types in "Rocky Mountain Gynecologic Oncology PC" are "Drug" (11 trials), "Other" (10 trials), "Biological" (9 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (9 trials), "Laboratory Biomarker Analysis" (8 trials), "Bevacizumab" (7 trials), "Carboplatin" (7 trials) and "Quality-of-Life Assessment" (7 trials). Other intervention names were less common.

The vast majority of trials in "Rocky Mountain Gynecologic Oncology PC" are 10 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Rocky Mountain Gynecologic Oncology PC". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Rocky Mountain Gynecologic Oncology PC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rocky Mountain Gynecologic Oncology PC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".